Re-emergence of Parechovirus: 2017-2022 National Trends of Detection in Cerebrospinal Fluid
- PMID: 36968966
- PMCID: PMC10034751
- DOI: 10.1093/ofid/ofad112
Re-emergence of Parechovirus: 2017-2022 National Trends of Detection in Cerebrospinal Fluid
Abstract
Increasing parechovirus (PeV) infections prompted a Centers for Disease Control and Prevention Health Advisory in July 2022. We retrospectively assessed national PeV trends in cerebrospinal fluid and observed unexpected viral dynamics from 2020 to 2022 with regional variance. These findings may be due to mitigation strategies aimed at severe acute respiratory syndrome coronavirus 2. PeV testing can benefit ill patients, particularly children.
Keywords: Epidemiology; Meningitis; Pediatrics.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. D.C.G.: reagents from IDbyDNA, Inc., and Illumina, Inc.; consulting for bioMérieux. R.M.H.: research support from bioMérieux; consulting for bioMérieux. The other authors report no potential conflicts of interest.
Figures
References
-
- Kadambari S, Harvala H, Simmonds P, Pollard AJ, Sadarangani M. Strategies to improve detection and management of human Parechovirus infection in young infants. Lancet Infect Dis 2019; 19:e51–8. - PubMed
-
- Kabuga AI, Nejati A, Soheili P, Shahmahmoodi S. Human Parechovirus are emerging pathogens with broad spectrum of clinical syndromes in adults. J Med Virol 2020; 92:2911–6. - PubMed
-
- de Jong EP, van den Beuken MGA, van Elzakker EPM, et al. . Epidemiology of sepsis-like illness in young infants: major role of enterovirus and human Parechovirus. Pediatric Infect Dis J 2017; 37:113–8. - PubMed
-
- Centers for Disease Control and Prevention . Recent reports of human Parechovirus (PeV) in the United States—2022. Available at: https://emergency.cdc.gov/han/2022/han00469.asp. Accessed 26 September 2022.
